170384 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates; Assays involving proteins of known structure or function as defined in the subgroups; Details Calcium binding proteins, e.g. calmodulin
MULTI-PROTEIN BIOMARKER ASSAY FOR BRAIN INJURY DETECTION AND OUTCOME
#2REGULATION OF IMMUNE RESPONSES THROUGH SELECTIVE NEURAL ACTIVATION
#3CALPROTECTIN BINDING PEPTIDES
#4KITS AND METHODS TO DISTINGUISH FALSE LABOR AND TRUE LABOR
#5BIOMARKERS FOR OVARIAN CANCER
#6ORAL MESENCHYMAL STEM CELLS AND USE THEREOF
#7BIOMARKERS AND THEIR USE IN DIAGNOSING PARKINSON'S DISEASE, VITREORETINAL DISEASES, AND AGE-RELATED PATHOLOGIES
#8LUMINESCENT METAL BINDING PROTEINS AND PEPTIDES FOR USE IN MICROSCOPY
#9ANTI-IL-23P19 ANTIBODY REGULATION OF GENES INVOLVED IN BOWEL URGENCY IN ULCERATIVE COLITIS
#10RADIOIMMUNOCONJUGATES TARGETING CALRETICULIN FOR USE IN THE TREATMENT OF CANCER
#11METHODS OF DETECTING AND REDUCING CANCER CELL CENTRAL NERVOUS SYSTEM COLONIZATION
#12Kits and methods to distinguish false labor and true labor
#13Biofluid-Based Methods for Diagnosing Alzheimer’s Disease-Associated Conditions
#14COMPOSITIONS AND METHODS TARGETING S100A10 FOR THE TREATMENT AND DIAGNOSIS OF LIVER CANCER
#15REGULATION OF IMMUNE RESPONSES THROUGH SELECTIVE NEURAL ACTIVATION
#16KIDNEY FUNCTION BIOMARKERS
#17Chemigenetic calcium indicators
#18METHODS, COMPOSITIONS, AND KITS FOR DETECTING AND MEASURING ENDOTHELIAL INJURY IN NORMAL AND DISEASED HUMAN CENTRAL NERVOUS SYSTEM (CNS)
#19ANIMAL MODEL, METHODS FOR MAKING AND USING THEREOF, AND COMPOSITION FOR TREATING ATAXIA
#20ELECTROCHEMICAL IMMUNOSENSOR FOR DETECTION OF CALPROTECTIN
#21METHODS FOR DETERMINING THE CONCENTRATION OF AN ANALYTE IN THE PLASMA FRACTION OF A SAMPLE OF WHOLE BLOOD
#22Calprotectin Assay
#23Biomarkers for diagnosing implant related risk of implant revision due to aseptic loosening
#24Biomarkers for diagnosing implant related risk of implant revision due to aseptic loosening
#25MULTI-PROTEIN BIOMARKER ASSAY FOR BRAIN INJURY DETECTION AND OUTCOME
#26ASSAY FOR RAPID EVALUATION OF CHOROIDAL MAST CELL DEGRANULATION
#27MUTANT CALRETICULIN FOR THE DIAGNOSIS OF MYELOID MALIGNANCIES
#28RAPID TEST FOR DIAGNOSIS OF BACTERIAL INFECTIONS IN NEONATES
#29MARKERS AND THEIR USE IN BRAIN INJURY
#30Kits and methods to distinguish false labor and true labor
#31METHODS OF DETECTING AND REDUCING CANCER CELL CENTRAL NERVOUS SYSTEM COLONIZATION
#32METHODS OF DETECTING MARKERS FOR INFLAMMATORY CONDITIONS AND FOOD SENSITIVITY IN COMPANION ANIMALS
#33Compounds inhibiting Nef-calnexin interaction
#34Method for determination of members of the S100 family of calcium binding proteins by immunoturbidimetry
#35METHODS AND DEVICES FOR DETECTING DIABETIC NEPHROPATHY AND ASSOCIATED DISORDERS
#36METHODS, USES AND KITS FOR MONITORING OR PREDICTING RESPONSE TO PERIODONTAL DISEASE TREATMENT
#37Detection of autoantibodies for diagnosing degenerative diseases of the skeletal system
#38Uses
#39PERIODONTAL DISEASE DIAGNOSTIC METHODS, USES AND KITS
#40Compounds inhibiting Nef-calnexin interaction
#41Chemigenetic calcium indicators
#42Biosensors and methods for detection of lysophosphatidic acid for signaling of ovarian cancer
#43METHOD FOR DETERMINATION OF A PROTEIN
#44Multi-protein biomarker assay for brain injury detection and outcome
#45METHOD FOR DIAGNOSIS OF UNSTABLE ATHEROSCLEROTIC PLAQUES
#46MARKERS AND THEIR USE IN BRAIN INJURY
#47Quantitative profiling of progesterone metabolites for the prediction of spontaneous preterm delivery
#48Use of IGFBP-7 in the assessment of heart failure
#49Soluble CD33 for treating myelodysplastic syndromes (MDS)
#50Mutant calreticulin for the diagnosis of myeloid malignancies
#51S100A8/S100A9-induced immunotolerance in newborn subjects
#52Biomarkers for diagnosing implant related risk of implant revision due to aseptic loosening
#53Uses
#54Complex-specific standardization of immunological methods for the quantification of S100A12
#55Calcium binding protein, spermatid specific 1, as a biomarker for diagnosis or treatment of stress
#56Automated method for assessing cancer risk using tissue samples, and system therefor
#57Kit for a Determination Method for Calprotectin and the Use of Calprotectin as a Predictive Marker for Cardiovascular Disease
#58Compounds inhibiting Nef-calnexin interaction
#59Compounds and methods for the synthesis of 5-(N-protected-tryptaminocarboxyamide)-2′-deoxyuridine phosphoramidite for incorporation into a nucleic acid
#60Method of detecting a substance
#61Methods of detecting and reducing cancer cell central nervous system colonization
#62MARKERS FOR CORONARY ARTERY DISEASE AND USES THEREOF
#63Methods of detecting markers for inflammatory conditions and food sensitivity in companion animals
#64Kits and methods to distinguish false labor and true labor
#65Methods of detecting markers for inflammatory conditions and food sensitivity in companion animals
#66Genetically encoded calcium indicators and methods of use
#67MUTANT CALRETICULIN FOR THE DIAGNOSIS OF MYELOID MALIGNANCIES
#68MARKERS AND THEIR USE IN BRAIN INJURY
#69Method for evaluating the possibility of suffering from pancreatic disease
#70Antibodies to endoplasmin and their use
#71KIDNEY FUNCTION BIOMARKERS
#72Secreted Protein Acidic and Rich in Cysteine (SPARC) Protein SRM/MRM Assay
#73URANIUM-CHELATING PEPTIDES AND USES THEREOF
#74Inflammasome activation in myelodysplastic syndromes
#75METHODS OF DETECTING INFLAMMATORY MARKERS AND TREATING INFLAMMATORY CONDITIONS IN HUMANS
#76COMPOUNDS AND METHODS FOR THE DETECTION OF CALPROTECTIN
#77Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders
#78Immunobiosensor and sensor system including the same
#79Quinoline-3-carboxamide compounds and their use in diagnosis
#80Genetically encoded calcium indicators and methods of use
#81Aptamers for purifying and quantifying gelsolin and its variants
#82In vivo detection of proteins interaction based on adenylate cyclase hybrid system
#83Uses
#84USE OF PROTEIN S100A12 AS A MARKER FOR COLORECTAL CANCER
#85Method for determination of a protein
#86TREATMENT OF MULTIPLE SCLEROSIS BY INHIBITION OF ALLOGRAFT INFLAMMATORY FACTOR-1
#87METHOD FOR SUGGESTING THE STAGE OF PROGRESSION OF PANCREATIC CANCER
#88S100P AND HYALURONIC ACID AS BIOMARKERS FOR METASTATIC BREAST CANCER
#89Use of IGFBP-7 in the assessment of heart failure
#90Cadherins as cancer biomarkers
#91METHODS AND COMPOSITIONS FOR SELF-ASSEMBLY SYSTEM OF NANOPARTICLES AND MICROPARTICLES FOR MULTI-TARGETING SPECIFICITY
#92Anti-S100A7 antibodies for the treatment and diagnosis of cancer
#93Mutant calreticulin for the diagnosis of myeloid malignancies
#94Diagnostic reagents and methods specific to inner ear disorders
#95Bimolecular protease-based biosensor
#96Soluble CD33 for treating myelodysplastic syndromes (MDS)
#97Antibodies to endoplasmin and their use
#98Multi-protein biomarker assay for brain injury detection and outcome
#99Red genetically encoded calcium indicators and methods of use
#100Anti-S100A4 antibody molecules and their uses
#101BIOMARKERS FOR PREDICTING THE SENSITIVITY OF CELLS TO IMMUNOMODULATORY COMPOUNDS DURING TREATMENT OF NON-HODGKIN'S LYMPHOMA
#102Kits for Fecal Neopterin Concentration Measurement as an Indicator of Disease Activity in Inflammatory Bowel Disease
#103Pre-eclampsia biomarkers
#104Method for treating muscle-invasive bladder cancer, containing S100A9 and EGFR inhibitors and cisplatin as active ingredients
#105Methods for determining risk of chronic lung allograft dysfunction (CLAD) and subtypes thereof
#106System and Methods of Detecting and Demonstrating Ultraviolet Damage to Hair Via Evaluation of Protein Fragments
#107CC2D2A gene mutations associated with Joubert syndrome and diagnostic methods for identifying the same
#108Genetically encoded calcium indicators and methods of use
#109ANALYSIS OF COMPOUNDS FOR PAIN AND SENSORY DISORDERS
#110Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders
#111Method for testing for nephritis-lesion sites and reagent therefor
#112PROCESSES AND KITS TO DETECT AND MONITOR FOR DIAGNOSTIC BIOMARKERS FOR POST TRAUMATIC STRESS DISORDER (PTSD) AND TO DIFFERENTIATE BETWEEN SUICIDAL AND NON-SUICIDAL FORM OF THE DISORDER
#113Diagnostic marker for treatment of cerebral ischemia
#114Green-to-red photo-convertible fluorescent calcium indicator
#115Mutations In Calmodulin Genes
#116Kit for diagnosing malignant melanoma
#117USE OF PROTEIN S100A12 AS A MARKER FOR COLORECTAL CANCER
#118SPARC AND METHODS OF USE THEREOF
#119COMPOSITIONS AND METHODS FOR ASSESSING GASTROINTESTINAL HEALTH
#120MATERIALS AND METHODS FOR DIAGNOSING AND TREATING SHELLFISH ALLERGY
#121SPARC and methods of use thereof
#122CALPROTECTIN AND HEMOGLOBIN/HAPTOGLOBIN COMPLEX FROM STOOL SAMPLE TO ASSESS COLORECTAL CANCER
#123BIOMARKERS OF PULMONARY HYPERTENSION
#124METHOD FOR IDENTIFYING DISEASE ASSOCIATED WITH ABUNDANCE OF TDP-43 IN CELL
#125BIOMARKERS AND TEST PANELS USEFUL IN SYSTEMIC INFLAMMATORY CONDITIONS
#126METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#127KIDNEY FUNCTION BIOMARKERS
#128Use of complex forms of calmodulin-like skin protein CLSP
#129Genetically encoded calcium indicators
#130Biomarkers for head-and-neck cancers and precancers
#131Antibodies to endoplasmin and their use
#132Secreted protein acidic and rich in cysteine (SPARC) protein SRM assay
#133CC2D2A gene mutations associated with joubert syndrome and diagnostic methods for identifying the same
#134FECAL NEOPTERIN CONCENTRATION MEASUREMENT AS AN INDICATOR OF DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASE
#135MATERIALS AND METHODS FOR DIAGNOSING AND TREATING SHELLFISH ALLERGY
#136Method for determination of sensitivity to anti-cancer agent
#137SYNERGISTIC BIOMARKER ASSAY OF NEUROLOGICAL CONDITION USING S-100B
#138CYBP as a marker for lung cancer
#139BIOMARKERS FOR EARLY DIAGNOSIS OF SYSTEMIC TISSUE FIBROSIS
#140Antibodies to endoplasmin and their use
#141CVD ASSAY
#142Methods and Devices for Detecting Kidney Transplant Rejection
#143CALPROTECTIN AND HEMOGLOBIN/HAPTOGLOBIN COMPLEX FROM STOOL SAMPLE TO ASSESS COLORECTAL CANCER
#144BIOMARKERS FOR MONITORING THE TREATMENT BY QUINAZOLINONE COMPOUNDS
#145Uranium-chelating peptides and uses thereof
#146Devices for Detecting Renal Disorders
#147Methods and Devices for Detecting Kidney Damage
#148Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders
#149Computer Methods and Devices for Detecting Kidney Damage
#150Methods and devices for detecting obstructive uropathy and associated disorders
#151Methods and Devices for Detecting Glomerulonephritis and Associated Disorders
#152COMPOSITION AND METHOD FOR DIAGNOSIS OR DETECTION OF RENAL CANCER
#153Method for determination of sensitivity to anti-cancer agent
#154METHOD FOR DIAGNOSIS OF INFLAMMATORY DISEASES USING CALGRANULIN C
#155Method for detection of cancer
#156CC2D2A gene mutations associated with Joubert syndrome and diagnostic methods for identifying the same
#157USE OF IGFBP-7 IN THE ASSESSMENT OF HEART FAILURE
#158Use of complex forms of calmodulin-like skin protein CLSP
#159Assays for S100 inhibitors
#160Methods and kits for the rapid determination of patients at high risk of death during severe sepsis and septic shock
#161Biomarkers for ovarian cancer
#162Uranium-chelating peptides and uses thereof
#163Sparc and methods of use thereof
#164USE OF PROTEIN S100A12 AS A MARKER FOR COLORECTAL CANCER
#165Use of MRP 8/14 levels for discrimination of individuals at risk of acute coronary syndromes
#166BIOMARKERS FOR PREDICTING THE SENSITIVITY OF CELLS TO IMMUNOMODULATORY COMPOUNDS DURING TREATMENT OF NON-HODGKIN'S LYMPHOMA
#167Diagnostic kit for malignant melanoma
#168Modulation of synaptogenesis
#169METHOD FOR SCREENING FERTILITY AND NEW COMPOUNDS OR MOLECULES, USING CRT OR ERP57 TRANSLOCATION
#170Non-invasive real-time in vivo bioluminescence imaging of local Ca+ dynamics in living organisms
#171Method for Detecting Conformational Change of Calmodulin, a Method for Screening a Substance Having an Activity that Affects to Conformational Change of Calmodulin
#172Photoreactive compound specifically binding to calcium binding proteins
#173Method for Identifying and Producing Effectors of Calmodulin-Dependent Peptidyl-Prolyl Cis/Trans Isomers
#174Method to evaluate the likelehood of development of bone metastasis based on the determination of calcium binding proteins
#175SPARC and methods of use thereof
#176Polypeptide complex of TRPM8 and calmodulin and its uses thereof
#177Use of calcium binding proteins to improve cardiac contractile function
#178Determination method for calprotectin and the use of calprotectin as a predictive marker for cardiovascular disease
#179Biomarkers for intro-amniotic inflammation
#180Method of diagnosis of inflammatory diseases using calgranulin c
#181Methods and systems for prognosis and diagnosis of brain damage